263 Results (Page 18 of 22)
All Free Sample Market Research Reports
India Osteoarthritis Drugs Market Analysis Sample Report
Osteoarthritis is the most prevalent joint disease with 22% to 39% prevalence in India. The India osteoarthritis drugs market is projected to grow as osteoarthritis continues to be the most prevalent disorder affecting the elderly population in India. Zydus Cadila and Sun Pharma are some of the key players in the market.
India Dermatological Therapeutics Market Analysis Sample Report
The India dermatological therapeutics market is projected to grow from $632 Mn in 2022 to $1,504 Mn in 2030 with a CAGR of 11.44% for the forecast period 2022-2030. Major dermatological disorders include eczema, tinea pedis, and angioedema. Corticosteroids and retinoids are some of the common drugs used for the treatment of dermatological conditions.
India Ophthalmology Therapeutics Market Analysis Sample Report
The growing burden of diabetic retinopathies and glaucoma in the Indian population and the increase in demand for technological advancements for the treatment of eye disorders are responsible for the growth of the India ophthalmology therapeutics market. The market is segmented by drug class and by dosage form.
India Anti-Aging Drugs Market Analysis Sample Report
The concept of anti-aging is gaining momentum in the market as the effects of aging such as skin elasticity loss and collagen loss are observed in the Indian population. As a result of this, the India anti-aging drugs market is expected to grow during the forecast period. The market is segmented by type and by treatment.
India Neurology Devices Market Analysis Sample Report
The increasing rate of neurological disorders in India has resulted in the India neurology devices market to grow from $230 Mn in 2022 to $521 Mn in 2030 with a CAGR of 10.8% for the year 2022-2030. Stroke, brain injuries, and epilepsy are the most prevalent neurological disorders in India.
Global OTC Ophthalmic Drugs Market Analysis Sample Report
Glaucoma and dry eye are the most common eye disorders affecting the population globally, hence the demand for Over The Counter (OTC) drugs is on the rise thereby leading to the growth of the Global OTC ophthalmic drugs market. The market is segmented by indication and by dosage form.
Global Patient Support Program Market Analysis Sample Report
Global Patient Support Programs (PSP) market is projected to grow during the forecast period as a result of more pharma companies investing in these programs and due to the rise in the demand for personalized medicine. Connect 360 by AstraZeneca and Assist 360 by Amgen are some of the top pharma-sponsored PSP programs.
Canada OTC Market Analysis Sample Report
The market size of Canada OTC market was valued at $13.62 Bn in 2022 to $23.58 Bn in 2030 with a CAGR of 7.1% for the year 2022-2030. The Canada OTC market is segmented by drug type and by distribution channel. Johnson and Johnson and Pfizer are some of the key players in the market.
Brazil OTC Pharmaceutical Market Analysis Sample Report
The Brazil OTC pharmaceuticals market is projected to grow from $4.25 Bn in 2022 to $7.93 Bn in 2030 with a CAGR of 8.1% for the year 2022-2030. Greater accessibility of the otc drugs and switching of prescription drugs to otc drugs are the major market drivers of Brazil otc pharmaceuticals market.
Brazil Ophthalmology Therapeutics Market Analysis Sample Report
Brazil ophthalmology therapeutics market is projected to grow owing to the increasing demand for high-innovation combination therapies for the treatment of glaucoma and other eye-related disorders. The market is segmented by indication and by end users.
Australia Physiotherapy Market Analysis Sample Report
The Australia physiotherapy market is expected to witness growth from $638 Mn in 2022 to $1,126 Mn in 2030 with a CAGR of 7.35% for the year 2022-2030. Arthritis, osteoporosis and back pain are the major conditions that require physiotherapy. The market is segmented by treatments and conditions.
APAC Autoimmune Hemolytic Anemia Market Analysis Sample Report
The APAC Autoimmune Hemolytic Anemia (AIHA) market is expected to grow as a result of the increased prevalence of AIHA in the APAC region. The market is segmented by disease type, therapy type, drugs, and by route of administration. AstraZeneca and Roche are some of the key players in the APAC AIHA market.